Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluations of CYP 450 Inhibition and Anticoagulation Biomarker Alteration by Radix Puerariae Lobatae (Gegen): Impact on Its Potential Herb-drug Interactions

NCT07823140 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.

NCT NCT07823140
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07823140 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluations of CYP 450 Inhibition and Anticoagulation Biomarker Alteration by Radix Puerariae Lobatae (Gegen): Impact on Its Potential Herb-drug Interactions
Lead sponsor
Chinese University of Hong Kong
Phase
Phase 1
Overall status
Completed
Start date
August 8, 2022
Completion date
April 28, 2023
Enrollment
56 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

herb-drug interactions